Zydus Lifesciences Limited — Updates, 15-01-2026: General Updates
15-01-2026 | 05:28 pm
15-01-2026 | 05:28 pm
Zydus completed its acquisition of Agenus Inc.'s US biologics manufacturing facilities and a 5.9% equity stake. This establishes Zylidac Bio LLC, launching Zydus into global biologics CDMO services. It also secured exclusive commercial rights for Agenus therapies in India/Sri Lanka.
No comments yet. Be the first to comment!
